Company Profiles

driven by the PitchBook Platform

Gemmus Pharma

Description

Developer of therapeutics for the treatment of influenza and other infectious diseases. The company develops GP1681, a non-peptidic eiconsanoid analog that is used for the treatment of influenza infections that require hospitalization as either a stand-alone treatment or co-therapy with an antiviral drug, as oseltamivir. It is also developing EP2 and EP4 agonists for the treatment of influenza.

2007

Founded

PRIVATE

Status

1-10

Employees

Angel

Latest Deal Type

$1.2M

Latest Deal Amount

$7.98M

Total Amount Raised

Description

Developer of therapeutics for the treatment of influenza and other infectious diseases. The company develops GP1681, a non-peptidic eiconsanoid analog that is used for the treatment of influenza infections that require hospitalization as either a stand-alone treatment or co-therapy with an antiviral drug, as oseltamivir. It is also developing EP2 and EP4 agonists for the treatment of influenza.

Website:

www.gemmuspharma.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology

Primary Office

409 Illinois Avenue San Francisco, CA 94158United States +1 (415) 978-2151
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Gemmus Pharma's full profile, request a free trial.

    Gemmus Pharma Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Gemmus Pharma Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Gemmus Pharma Investors (7)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    BlueTree Allied AngelsVenture CapitalMinority000 0000000 0000
    Individual InvestorAngel (individual)Minority000 0000000 0000
    Life Science AngelsAngel GroupMinority000 0000000 0000
    Tech Coast AngelsAngel GroupMinority000 0000000 0000
    The Angels' ForumAngel GroupMinority000 0000000 0000
    BlueTree Allied Angels Venture Capital
    Individual Investor Angel (individual)
    Life Science Angels Angel Group
    Tech Coast Angels Angel Group
    The Angels' Forum Angel Group

    Gemmus Pharma Executive Team (4)

    NameTitleBoard
    Seat
    Contact
    Info
    Daryl Faulds Ph.DChief Executive Officer & Board Member
    William Guilford Ph.DPresident, Board Member & Co-Founder
    Jonathan RossChief Financial Officer
    William HolsteinSenior Vice President, Business Development
    Daryl Faulds Ph.D Chief Executive Officer & Board Member
    William Guilford Ph.D President, Board Member & Co-Founder
    Jonathan Ross Chief Financial Officer
    William Holstein Senior Vice President, Business Development

    Gemmus Pharma Board Members (4)

    NameRepresentingRoleSinceContact
    Info
    Christopher Dunn MDSelfBoard Member000 0000
    Daryl Faulds Ph.DGemmus PharmaChief Executive Officer & Board Member000 0000
    Larry MillerSelfBoard Member000 0000
    Marc Rubin MDSelfBoard Member000 0000
    Christopher Dunn MD Board Member Self
    Daryl Faulds Ph.D Chief Executive Officer & Board Member Gemmus Pharma
    Larry Miller Board Member Self
    Marc Rubin MD Board Member Self
    Request full access to PitchBook